Omega Healthcare Investors, Inc. (OHI)

NYSE: OHI · USD

$45.6

-0.50 (-1.1%)· Recorded snapshot

Market cap	14.5B
Revenue (ttm)	1.3B
Net income (ttm)	842M
EPS (ttm)	$2.80
Shares out	316.9M
P/E (trailing)	16.3x
P/E (forward)	26.0x
Dividend	$2.72 (5.97%)
Volume	1,938,461
Beta	0.53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3B
Net income (ttm): 842M
EPS (ttm): $2.80
P/E (trailing): 16.3x
P/E (forward): 26.0x
Market cap: 14.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AMT	American Tower Corporation	85.1B	25.8x	7.5x	7.8%	+4.0%	+0.7%	Reducir
ARE	Alexandria Real Estate Equities Inc.	6.9B	—	2.4x	0.9%	+6.6%	-45.8%	Mantener
CCI	Crown Castle Inc.	37.4B	46.3x	9.1x	5.1%	-7.9%	-6.2%	Vender

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E26

P25 n/aP50 n/aP75 n/a

Trailing P/E16.3

P25 n/aP50 n/aP75 n/a

ROE16.5

P25 n/aP50 n/aP75 n/a

ROIC8.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All OHI indicators

Market & fundamental data

Available fields

270

Groups with data

Currency

USD

Showing 270 of 270 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000888491
Company name	Omega Healthcare Investors, Inc.
Country	United States
Country code	US
CUSIP number	681936100
Earnings date	2026-11-03
Earnings time	amc
Employees	69
Employees change	9
Employees growth	15%
Enterprise value	$18.5B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Industry	REIT - Healthcare Facilities
Is primary listing	Yes
Is SPAC	No
ISIN number	US6819361006
Last 10-K release date	2026-02-09
Last earnings date	2026-07-29
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$14.5B
Market cap category	Large-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$45.63
Price currency	USD
Sector	Real Estate
SIC code	6798
Stock price date	2026-10-28
Symbol	OHI
U.S. state	Maryland
Website	https://www.omegahealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	16.21x
Average P/E ratio (10Y)	28.07x
Average P/E ratio (3Y)	25.67x
Average P/E ratio (5Y)	22.88x
Earnings yield	6.15%
EV/Earnings	21.97x
EV/EBIT	22.9x
EV/EBITDA	16.24x
EV/FCF	40.62x
EV/Sales	14.67x
FCF / EV yield	2.46%
FCF yield	3.14%
Forward EV/Sales	16.49x
Forward P/E	25.99x
Forward P/S	12.93x
Graham number	33.72292
Graham upside	-26.34%
Industry forward P/E	66.06x
Industry P/E	78.26x
Lynch fair value	$70.11
Lynch upside	53.16%
P/(FCF - SBC) ratio	36.06x
P/(OCF - SBC) ratio	17.33x
P/B ratio	2.56x
P/E ratio	16.27x
P/FCF ratio	31.85x
P/FFO ratio	14.71x
P/OCF ratio	16.29x
P/S ratio	11.5x
PEG ratio	6.89x
Price / tangible book value	3.07x
Price/EBITDA ratio	12.74x
Sector forward P/E	29.99x
Sector P/E	40.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	64.07%
EBITDA margin	90.3%
Effective tax rate	1.79%
FCF margin	36.11%
Gross margin	97.92%
Operating margin	64.07%
Pretax margin	72.26%
Profit margin	68.06%
Profit per employee	$12.2M
Profitable quarters	23
Profitable years	21
Revenue per employee	$18.3M
ROA	4.91%
ROA (5Y)	3.72%
ROCE	9.01%
ROE	16.53%
ROE (5Y)	10%
ROIC	8.11%
ROIC (5Y)	6%
SBC / revenue	4.22%
Tax / revenue	1.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	73.68%
EPS growth (Q)	161.32%
EPS growth (QoQ)	156.15%
EPS growth 10Y	5.7%
EPS growth 3Y	39.79%
EPS growth 5Y	24.88%
EPS growth quarters	11
EPS growth years	2
Net income growth	82.36%
Net income growth (Q)	165.61%
Net income growth (QoQ)	158.07%
Net income growth 3Y	51.19%
Net income growth 5Y	31.44%
Net income growth quarters	11
Net income growth years	2
OCF growth	6.65%
OCF growth (Q)	-9%
OCF growth (QoQ)	1.03%
OCF growth 10Y	4.79%
OCF growth 3Y	13.93%
OCF growth 5Y	3.3%
Revenue growth	13.16%
Revenue growth (Q)	11.24%
Revenue growth (QoQ)	-0.64%
Revenue growth 10Y	3.97%
Revenue growth 3Y	13.94%
Revenue growth 5Y	6.65%
Revenue growth quarters	13
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-435M
Depreciation and amortization	$330.8M
EBIT	$808.1M
EBITDA	$1.1B
EPS	$2.80
FCF per share	$1.44
Financing cash flow	$-1.7B
Free cash flow	$455.5M
Free cash flow minus SBC	$402.3M
Funds from operations (FFO)	$975.1M
Gross profit	$1.2B
Income taxes	$16.3M
Investing cash flow	$186.5M
Net cash flow	$-588.4M
Net income	$842M
Operating cash flow minus SBC	$837.4M
Operating income	$808.1M
Revenue	$1.3B
Stock-based compensation	$53.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$18.02
Debt / EBITDA	3.53
Debt / equity	0.71
Debt / FCF	8.85
Goodwill	$644.4M
Interest coverage	3.89
Net cash (debt)	$-4B
Net cash / market cap	-27.53%
Net debt / EBITDA	3.51
Net debt / equity	0.71
Net debt / FCF	8.77
Piotroski F-Score	5
Property, plant and equipment	$6.5B
Shareholders' equity	$5.6B
Tangible book value	$4.7B
Tangible book value per share	$15.78
Total assets	$10B
Total cash	$39M
Total debt	$4B
Total liabilities	$4.4B
WACC	6.69%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.12
Current ratio	0.44
Net working capital	$89.5M
Quick ratio	0.3
Working capital	$-579.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-7.91%
Dividend growth	0.75%
Dividend growth (10Y)	1.36%
Dividend growth (3Y)	0.25%
Dividend growth (5Y)	0.15%
Dividend growth years	0
Dividend payment date	2026-11-16
Dividend payment years	24
Dividend payout frequency	Quarterly
Dividend per share	$2.72
Dividend yield	5.97%
Ex-dividend date	2026-11-05
FCF payout ratio	189.23%
Last dividend	$0.68
Payout ratio	96.98%
Shareholder yield	-1.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	46.49%
10Y return CAGR	12.22%
10Y total return	216.55%
150-day SMA	$46.81
15Y price change	151.47%
15Y return CAGR	14.37%
15Y total return	648.92%
1D price change	-1.08%
1M price change	-1.82%
1M total return	-1.82%
1W price change	-0.24%
1W total return	-0.24%
1Y price change	11.05%
1Y return CAGR	17.79%
1Y total return	17.78%
20-day SMA	$45.30
200-day SMA	$46.59
20Y price change	173.74%
20Y return CAGR	13.14%
20Y total return	1,081.26%
3M price change	-11.6%
3M total return	-10.39%
3Y price change	37.91%
3Y return CAGR	19.42%
3Y total return	70.34%
50-day SMA	$46.14
50-day SMA vs 200-day SMA	50under200
52-week high	$52.39
52-week high date	2026-07-30
52-week low	$39.26
52-week low date	2025-10-29
5Y price change	51.67%
5Y return CAGR	17.6%
5Y total return	124.89%
6M price change	-2.64%
6M total return	0.12%
All-time high	$52.39
All-time high date	2026-07-30
All-time low	$1.35
All-time low date	2001-04-27
Average true range (ATR)	$0.99
Average volume	1.8M
Beta (1Y)	-0.12
Beta (2Y)	0.08
Beta (5Y)	0.53
Change from 52-week high	-12.9%
Change from 52-week low	16.23%
Change from all-time high	-13.27%
Change from all-time low	3,265.93%
Change from open	0.13%
Day's gap	-1.21%
Dollar volume	$88.5M
High price	$45.89
Low price	$45.08
Monthly RSI	55.72
Open price	$45.57
Position in 52-week range	67.9%
Premarket change	-0.67%
Premarket close	$46.13
Premarket price	$45.82
Premarket volume	338
Previous close	$46.13
Price vs 150-day SMA	-2.93%
Price vs 20-day SMA	0.3%
Price vs 200-day SMA	-2.46%
Price vs 50-day SMA	-1.53%
Relative volume	1.05
RSI	47.71
Sharpe ratio	0.68
Sharpe ratio (3Y)	0.76
Sharpe ratio (5Y)	0.58
Sortino ratio	1.36
Sortino ratio (3Y)	1.41
Sortino ratio (5Y)	1.11
Volume	1.9M
Weekly RSI	46.03
YTD price change	2.48%
YTD total return	6.96%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	302M
Float percentage	95.31%
Shares change (QoQ)	0.36%
Shares change (YoY)	7.91%
Shares held by insiders	0.21%
Shares held by institutions	83.27%
Shares outstanding	316.9M
Short % of float	5.23%
Short % of shares	4.99%
Short ratio	7.7 days

Deeper analysis on OHI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this OHI report

Is a complete OHI research report available?

No complete published report is available for Omega Healthcare Investors, Inc. (OHI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Omega Healthcare Investors, Inc. (OHI)

Price

Financial snapshot

Fair-value bridge

Latest news · OHI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All OHI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on OHI

Frequently asked questions